[Expression of pituitary tumor-transforming gene in patients with multiple myeloma]

Zhao Wang1, Quan-Yi Lu, Ping Chen

  • 1Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen 361012, China.

Insights

Pituitary tumor-transforming gene (PTTG) was overexpressed in elderly multiple myeloma (MM) patients. This finding suggests PTTG may play a role in the development and progression of MM.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Multiple myeloma (MM) is a cancer of plasma cells.
  • The role of specific genes in MM pathogenesis requires further investigation, particularly in elderly populations.

Purpose:

  • To investigate the expression levels of pituitary tumor-transforming gene (PTTG) in elderly patients diagnosed with multiple myeloma (MM).
  • To determine the correlation between PTTG expression and the presence or progression of MM.

Summary:

  • PTTG mRNA expression was quantified in bone marrow mononuclear cells (BMMNC) from 33 MM patients and 10 healthy controls using reverse transcriptase-polymerase chain reaction (RT-PCR).
  • Results indicated significantly higher PTTG mRNA expression in MM patients (0.3415 +/- 0.2172) compared to normal controls (0.0590 +/- 0.0233) (P < 0.05).
  • The oncogene PTTG's overexpression is implicated in the genesis and progression of multiple myeloma.

Impact:

  • This research suggests that PTTG may be a contributing factor to the development and advancement of multiple myeloma.
  • The findings offer novel insights for exploring the pathogenesis of MM and developing potential gene-targeted therapies.